Skip to main content
SpringerLink
Log in

Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: Effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Ro 11-2465 (cianopramine, cyan-imipramine) and citalopram (CIT), putative antidepressant drugs, are very potent and selective 5-hydroxytryptamine (5-HT) uptake inhibitors in vitro. This study investigated the effects of these drugs and their desmethyl metabolites, Ro 12-5419 (desmethylcianopramine, cyan-desipramine) and desmethylcitalopram (DCIT), respectively, on the uptake of 5-HT and noradrenaline (NA) in vivo [protection against H 77/77 (4, alpha-dimethyl-metatyramine)-induced displacement of 5-HT and NA] and on related pharmacological activities. All the investigated drugs antagonized H 77/77-induced displacement of 5-HT in the rat brain, though the effects of the metabolites were considerably weaker than those of the parent compounds. The H 77/77-induced displacement of brain NA in rats and mice was antagonized only by Ro 12-5419 and Ro 11-2465. All the drugs potentiated the pressor response to 5-HT in pithed rats; however, Ro 12-5419 and particularly Ro 11-2465 could also block the response when used in higher doses (≧0.1 mg/kg). Only Ro 12-5419 and Ro 11-2465 were able to potentiate the pressor response to NA. Ro 12-5419 also potentiated thyrotropin releasing hormone (TRH) hyperthermia and antagonized reserpine hypothermia in mice; Ro 11-2465 potentiated the TRH hyperthermia only. CIT and DCIT were inactive in both these tests. Of all the four drugs only CIT and Ro 12-5419 considerably stimulated the hind limb flexor reflex in spinal rats. However, whereas the stimulatory effect of CIT was inhibited by the 5-HT antagonists metergoline and cyproheptadine, that of Ro 12-5419 was counteracted by the NA antagonist phenoxybenzamine only. Ro 11-2465, when used in low doses (ca. 1 mg/kg), slightly potentiated the flexor reflex, whereas in higher doses (4–16 mg/kg) it had no effect itself but antagonized the stimulatory action of the 5-HT agonists fenfluramine, quipazine and LSD. The results obtained indicate that Ro 11-2465 and CIT, as well as their desmethyl metabolites, are also potent 5-HT uptake inhibitors in vivo. However, only CIT and DCIT are concurrently devoid of effect on uptake of NA. In contrast, Ro 11-2465 and particularly Ro 12-5419 appear to also inhibit the uptake of NA. Moreover, Ro 11-2465 appears to block central and peripheral 5-HT receptors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bruinvels J (1971) Evidence for inhibition of the re-uptake of 5-hydroxytryptamine and noradrenaline by tetrahydronaphthylamine. Br J Pharmacol 42:281–286

    Google Scholar 

  • Burkard WP (1980) Specific binding sites in rat brain for a new and potent inhibitor of 5-hydroxytryptamine uptake: Ro 11-2465. Eur J Pharmacol 61:409–410

    Google Scholar 

  • Carlsson A, Corrodi H, Fuxe K, Hökfelt T (1969a) Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine store caused by 4-methyl-α-ethyl-meta-tyramine. Eur J Pharmacol 5:357–366

    Google Scholar 

  • Carlsson A, Corrodi H, Fuxe K, Hökfelt T (1969b) Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine. Eur J Pharmacol 5:367–373

    Google Scholar 

  • Cavero I, Gomeni R, Lefèvre-Borg F, Roach AG (1980) Comparison of mianserin with desipramine, maprotiline and phentolamine on cardiac presynaptic and vascular postsynaptic α-adrenoceptors and noradrenaline reuptake in pithed normotensive rats. Br J Pharmacol 68:321–332

    Google Scholar 

  • Chang CC (1964) A sensitive method for spectrophotofluorometric assay of catecholamines. Int J Neuropharmacol 3:643–649

    Google Scholar 

  • Claassen V, Davies JE, Hertting G, Placheta P (1977) Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol 60:505–516

    Google Scholar 

  • Coppen A (1967) The biochemistry of affective disorders. Br J Psychiatry 113:1237–1264

    Google Scholar 

  • Costa e Silva JA, Omer LMO, Ismail S (1983) Cianopramine, a preliminary efficacy study with a new potent serotonin uptake inhibitor. Abstracts of the 7th World Congress of Psychiatry, Vienna (Austria), 11–16 July 1983, p 489, abstract P223

  • DaPrada M, Keller HH, Burkard WP, Schaffner R, Bonetti EP, Launay JM, Haefely W (1982) Some neuropharmacological effects of Ro 11-2465—a novel tricyclic antidepressant with potent inhibitory activity on the uptake of 5-HT. In Advances in biochemical psychopharmacology vol 31 (Typical and atypical antidepressants: Molecular mechanisms) pp 235–248

  • Desiles M, Rips R (1981) Use of potentiation of thyrotrophin releasing hormone (TRH)-induced hyperthermia as a test for screening antidepressants which active α-adrenoceptor systems. Br J Pharmacol 74:81–86

    Google Scholar 

  • Doogan DP (1980) Fluvoxamine as an antidepressant drug. Neuropharmacology 19:1215–1216

    Google Scholar 

  • Earley CJ, Leonard BE (1978) Isolation and assay of noradrenaline, dopamine, 5-hydroxytryptamine, and several, metabolites from brain tissue using disposable Bio-Rad columns packed with Sephadex G-10. J Pharmacol Methods 1:67–79

    Google Scholar 

  • Fredricson Overø K (1982a) Kinetics of citalpram in test animals; drug exposure in safety studies. Prog Neuro-Psychopharmacol Biol Psychiatr 6:297–309

    Google Scholar 

  • Fredricson Overø K (1982b) Kinetics of citalopram in man; plasma levels in patients. Prog Neuro-Psychopharmacol Biol Psychiatr 6:311–318

    Google Scholar 

  • Gillespie JS, Maclaren A, Pollock D (1970) A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol 40:257–267

    Google Scholar 

  • Gottlieb P, Wandall T, Fredricson Overø K (1980) Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand 62:236–244

    Google Scholar 

  • Haefely W, Schaffner R, Burkard WP, Da Prada M, Keller HH, Pole P, Richards JG (1978) Ro 11-2465, a potent and selective inhibitor of 5-hydroxytryptamine uptake. Abstracts of the 11th CINP Congress. Vienna (Austria), 9–14 July 1978, p 95

  • Horst WD, Spirt N (1974) A possible mechanism for the antidepressant activity of thyrotropin releasing hormone. Life Sci 15:1073–1082

    Google Scholar 

  • Hyttel J (1977) Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacology 51:225–233

    Google Scholar 

  • Hyttel J (1982) Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro-Psychopharmacol Biol Psychiatr 6:277–295

    Google Scholar 

  • Jones RB and Luscombe DK (1976) Plasma levels of clomipramine and its N-desmethyl metabolite following oral administration of clomipramine in man. Br J Pharmacol 57:430 P

    Google Scholar 

  • Jones RB and Luscombe DK (1977) Plasma concentrations of clomipramine and its N-desmethyl metabolite in depressive patients following treatment with various dosage regimes of clomipramine. Postgrad Med J 53 (Suppl. 4):63–76

    Google Scholar 

  • Keller HH, Burkard WP, Da Prada M (1980) Dopamine receptor blockade in rat brain after acute and subchronic treatment with tricyclic antidepressants. Adv Biochem Psychopharmacol vol 24 (Long-term effects of neuroleptics) pp 175–179

    Google Scholar 

  • Kragh-Sørensen P (1983) A controlled, double-blind multicentre trial comparing clomipramine and a new, highly selective 5-HT uptake inhibitor, citalopram (Lu 10-171). Abstracts of the 7th World Congress of Psychiatry, Vienna (Austrai), 11–16 July 1983, p 482, abstract P179

  • Lapin IP, Oxenkrug GF (1969) Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet I:132–136

    Google Scholar 

  • Lindbrink P, Jonsson G, Fuxe K (1971) The effect of imipramine-like drugs and antihistamine drugs on uptake mechanisms in the central noradrenaline and 5-hydroxytryptamine neurons. Neuropharmacology 10:521–536

    Google Scholar 

  • Lindegaard Pedersen O, Kragh-Sørensen P, Bjerre M, Fredricson Overø K, Gram LF (1982) Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long term effect — A phase II study. Psychopharmacology 77:199–204

    Google Scholar 

  • Maître L, Baumann PA, Jaekel J, Waldmeier PC (1982) 5-HT uptake inhibotors: psychopharmacological and neurobiochemical criteria of selectivity. Adv Biochem Psychopharm 34 (Serotonin in biological psychiatry): 229–246

  • Maître L, Moser P, Baumann PA Waldmeier PC (1980) Amine uptake inhibitors: Criteria of selectivity. Acta Psychiatr Scand 61 (Suppl. 280):97–110

    Google Scholar 

  • Maj J, Palider W, Baran L (1976) The effects of serotonergic and antiserotonergic drugs on the flexor reflex of spinal rat: a proposed model to evaluate the action on the central serotonin receptor. J Neural Transm 38:131–147

    Google Scholar 

  • Maj J, Rogóz Z, Skuza G (1982a) Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity. Eur J Pharmacol 81:287–292

    Google Scholar 

  • Maj J, Rogóz Z, Skuza G, Sowińska H (1983) The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine-and apomorphine-induced hypothermia in mice. Pol J Pharmacol Pharm 35:49–57

    Google Scholar 

  • Maj J, Stala L, Górka Z, Adamus A (1982b) Comparison of the pharmacological actions of desmethylclomipramine and clomipramine. Psychopharmacologyy 78:165–169

    Google Scholar 

  • Mertens C (1983) A controlled double-blind clinical trial with a new highly selective 5-HT-re-uptake inhibitor, citalopram (Lu 10-171) versus mianserin in depressed patients. Abstracts of the 7th World Congress of Psychiatry, Vienna (Austria), 11–16 July 1983, p 441, abstract F924

  • Pawŀowski L, Górka Z, Rogóz Z, Skuza G Rawŀów A, Maj J (1983) Some acute and chronic effects of talsupram, a potent and selective, bicyclic inhibitor of the uptake of noradrenaline. Abstracts of the 5th International Catecholamine, Symposium, Göteborg (Sweden), 12–16 June 1983, Prog Neuro-Psychopharmacol Biol Psychiatr (Suppl) p 245, abstract 377

  • Pawŀowski L, Kwiatek H (1983a) The effect of highly selective inhibitors of the uptake of noradrenaline or 5-hydroxytryptamine on TRH-induced hyperthermia in mice. Psychopharmacology 81:48–53

    Google Scholar 

  • Pawŀowski L, Kwiatek H (1983b) TRH-induced hyperthermia in mice: effect of NA and 5-HT uptake inhibitors. Abstracts of the 5th International Catecholamine Symposium, Göteborg (Sweden), 12–16 June 1983, Prog Neuro-Psychopharmacol Biol Psychiatr (Suppl.) p 235, abstract 378

  • Pawŀowski L, Kwiatek H, Górka Z (1981a) Is Ro 11-2465 (cyanimipramine) an antagonist of postsynaptic serotonin receptors? J Neural Transm 52:61–72

    Google Scholar 

  • Pawŀowski L, Kwiatek H, Ruczyńska J (1980) A comparison of effects of zimelidine with those of other inhibitors of the serotonin (5-HT) uptake. Abstracts of the 12th CINP Congress, Göteborg (Sweden), 22–26 June 1980, Prog Neuro-Psychopharmacol (Suppl.) p 277, abstract 516

  • Pawlowski L, Ruczyńska J, Górka Z (1981b) Citalopram: A new potent inhibitor of serotonin (5-HT) uptake with central 5-HT-mimetic properties. Psychopharmacology 74:161–165

    Google Scholar 

  • Petersen EN, Olsson S-O, Squires RF (1977) Effects of 5-HT uptake inhibitors on the pressor response to 5-HT in the pithed rat. The significance of the 5-HT blocking property. Eur J Pharmacol 43:209–215

    Google Scholar 

  • Przegaliński E, Siwanowicz J, Baran L, Bigajska K (1983) Antagonism by tricyclic antidepressants of reserpine-induced hypothermia in mice. Involvement of postsynaptic α2-adrenoceptors. Pol J Pharmacol Pharm 35:309–317

    Google Scholar 

  • Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522

    Google Scholar 

  • Schildkraut JJ, Kety SS (1967) Biogenic amines and emotion. Science 156:21–30

    Google Scholar 

  • Slater IH, Rathbun RC, Kattau R (1979) Role of 5-hydroxytryptaminergic and adrenergic mechanism in antagonism of reserpine-induced hypothermia in mice. J Pharm Pharmacol 31:108–110

    Google Scholar 

  • Träskman L, Åsberg M, Bertilsson L, Cronholm B, Mellström B, Neckers LM, Sjöqvist F, Thorén P, Tybring G (1979) Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression. Clin Pharmacol Ther 26:600–610

    Google Scholar 

  • van Praag HM (1974) Towards a biochemical typology of depression. Pharmacopsychiatry 7:281–292

    Google Scholar 

  • Øfsti E (1982) Citalopram —a specific 5-HT-reuptake inhibitor-as an antidepressant drug: A phase II multicentre trial. Prog Neuro-Psychopharmacol Biol Psychiatr 6:327–335

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Street, 31-343, Kraków, Poland

    L. Pawlowski, G. Nowak, Z. Górka & H. Mazela

Authors
  1. L. Pawlowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Nowak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z. Górka
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Mazela
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pawlowski, L., Nowak, G., Górka, Z. et al. Ro 11-2465 (cyan-imipramine), citalopram and their N-desmethyl metabolites: Effects on the uptake of 5-hydroxytryptamine and noradrenaline in vivo and related pharmacological activities. Psychopharmacology 86, 156–163 (1985). https://doi.org/10.1007/BF00431702

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00431702

Key words

Search

Navigation